An antigen signaling fate-mapping mouse reveals that intratumoral antigen signals trap CD8+ T cell clonal populations in tumors @SciImmunology@Thav_Lab
https://t.co/3cVIecyQZv
Applications for our 2024 PhD programme are open! Join us for…
🔬Innovative science
🗺️International, collaborative environment
🤝Structured programme, training and career support
💰£26,125 tax-free stipend + tuition and visa fees
Apply by 9 November ⤵️
https://t.co/VJmvN3DWPV
The June issue of Science #Immunology is out!
This month's cover features an analysis of tumor TRM cell characteristics in mice. Other studies looked at GAS-responsive T cells and psoriasis, as well as immune cell “neighborhoods” in the skin: https://t.co/ezcUCL4e3P
Researchers at the Crick and @KingsCollegeLon have made key findings about the way cancer interacts with surrounding immune cells. The findings, which could help discover new immunotherapy targets, were published in @GenomeMedicine
✍️ @hrvshrvs@fcicca
https://t.co/Uiz29TjAUi
🏃The Becker was well represented at the Manchester 10k yesterday by Helen Parker, @AnnaGrayNeuro, @GChattrakarn, Clara Whiteley, Olivia Shorthouse and Ivy Usansky as part of the @OfficialUoM#PurpleWave
👏Congratulations to everyone who took part!
🍺 COMPETITION TIME 🧠
It’s just 10 days until @pintofscience returns to Manchester! To celebrate, we’re giving away a FREE PINT GLASS to one person who retweets this tweet! Competition closes on 24/05/23 at midnight
Get your tickets here: https://t.co/xWBk4pFYRJ
#pint23
COVID UPDATE: All contacts of suspected Omicron cases must self-isolate for 10 days, regardless of their vaccination status. They will be contacted by NHS Test and Trace.
"#Antigen#presentation in #cancer: insights into tumour immunogenicity and immune evasion" @NatureRevCancer https://t.co/bHU27J3vL9 Jhunjhunwala et al. describe mechanisms of immune evasion by alteration of antigen repertoire presented on tumors @OncoAlert
NEW Review! S Jhunjhunwala, C Hammer & L Delamarre discuss recent insights into how antigen processing & presentation in cancer & immune cells, crucial for the success of #ImmuneCheckpoint inhibition, may be disrupted in tumours: https://t.co/GfkmlXZu1j
#ImmuneEvasion@genentech